360 related articles for article (PubMed ID: 8445432)
1. Randomized prospective comparison of intraventricular methotrexate and thiotepa in patients with previously untreated neoplastic meningitis. Eastern Cooperative Oncology Group.
Grossman SA; Finkelstein DM; Ruckdeschel JC; Trump DL; Moynihan T; Ettinger DS
J Clin Oncol; 1993 Mar; 11(3):561-9. PubMed ID: 8445432
[TBL] [Abstract][Full Text] [Related]
2. Intrathecal chemotherapy in carcinomatous meningitis from breast cancer.
Orlando L; Curigliano G; Colleoni M; Fazio N; Nole F; Martinelli G; Cinieri S; Graffeo R; Peruzzotti G; Goldhirsch A
Anticancer Res; 2002; 22(5):3057-9. PubMed ID: 12530042
[TBL] [Abstract][Full Text] [Related]
3. A randomized controlled trial comparing intrathecal sustained-release cytarabine (DepoCyt) to intrathecal methotrexate in patients with neoplastic meningitis from solid tumors.
Glantz MJ; Jaeckle KA; Chamberlain MC; Phuphanich S; Recht L; Swinnen LJ; Maria B; LaFollette S; Schumann GB; Cole BF; Howell SB
Clin Cancer Res; 1999 Nov; 5(11):3394-402. PubMed ID: 10589750
[TBL] [Abstract][Full Text] [Related]
4. Treatment of neoplastic meningitis with intraventricular thiotepa and methotrexate.
Trump DL; Grossman SA; Thompson G; Murray K; Wharam M
Cancer Treat Rep; 1982 Jul; 66(7):1549-51. PubMed ID: 6807542
[TBL] [Abstract][Full Text] [Related]
5. Breast cancer leptomeningeal metastasis: the results of combined treatment and the comparison of methotrexate and liposomal cytarabine as intra-cerebrospinal fluid chemotherapy.
Niwińska A; Rudnicka H; Murawska M
Clin Breast Cancer; 2015 Feb; 15(1):66-72. PubMed ID: 25287959
[TBL] [Abstract][Full Text] [Related]
6. Salvage Treatment with Intracerebrospinal Fluid Thiotepa in Patients with Leptomeningeal Metastasis After Failure of Methotrexate-based Treatment.
Cho KM; Kim YJ; Kim SH; Kim JW; Lee JO; Han JH; Lee KW; Kim JH; Kim CY; Bang SM; Kim IA; Kim JS; Lee JS
Anticancer Res; 2015 Oct; 35(10):5631-8. PubMed ID: 26408736
[TBL] [Abstract][Full Text] [Related]
7. Meningeal carcinomatosis in patients with breast carcinoma. Clinical features, prognostic factors, and results of a high-dose intrathecal methotrexate regimen.
Fizazi K; Asselain B; Vincent-Salomon A; Jouve M; Dieras V; Palangie T; Beuzeboc P; Dorval T; Pouillart P
Cancer; 1996 Apr; 77(7):1315-23. PubMed ID: 8608509
[TBL] [Abstract][Full Text] [Related]
8. Complications associated with intraventricular chemotherapy in patients with leptomeningeal metastases.
Chamberlain MC; Kormanik PA; Barba D
J Neurosurg; 1997 Nov; 87(5):694-9. PubMed ID: 9347977
[TBL] [Abstract][Full Text] [Related]
9. Involved-field radiotherapy and intra-Ommaya methotrexate/cytarabine in patients with AIDS-related lymphomatous meningitis.
Chamberlain MC; Dirr L
J Clin Oncol; 1993 Oct; 11(10):1978-84. PubMed ID: 7692000
[TBL] [Abstract][Full Text] [Related]
10. Meningeal carcinomatosis in breast cancer. Prognostic factors and influence of treatment.
Boogerd W; Hart AA; van der Sande JJ; Engelsman E
Cancer; 1991 Mar; 67(6):1685-95. PubMed ID: 2001559
[TBL] [Abstract][Full Text] [Related]
11. Concurrent radiotherapy and intrathecal methotrexate for treating leptomeningeal metastasis from solid tumors with adverse prognostic factors: A prospective and single-arm study.
Pan Z; Yang G; He H; Zhao G; Yuan T; Li Y; Shi W; Gao P; Dong L; Li Y
Int J Cancer; 2016 Oct; 139(8):1864-72. PubMed ID: 27243238
[TBL] [Abstract][Full Text] [Related]
12. The relevance of intraventricular chemotherapy for leptomeningeal metastasis in breast cancer: a randomised study.
Boogerd W; van den Bent MJ; Koehler PJ; Heimans JJ; van der Sande JJ; Aaronson NK; Hart AA; Benraadt J; Vecht ChJ
Eur J Cancer; 2004 Dec; 40(18):2726-33. PubMed ID: 15571954
[TBL] [Abstract][Full Text] [Related]
13. Quality-of-life-adjusted survival comparison of sustained-release cytosine arabinoside versus intrathecal methotrexate for treatment of solid tumor neoplastic meningitis.
Cole BF; Glantz MJ; Jaeckle KA; Chamberlain MC; Mackowiak JI
Cancer; 2003 Jun; 97(12):3053-60. PubMed ID: 12784341
[TBL] [Abstract][Full Text] [Related]
14. [Improved quality of life in a patient with carcinomatous meningitis from invasive lobular carcinoma treated with intrathecal MTX and Ara-C in combination with systemic docetaxel].
Kubo M; Jida M; Yamane M; Miyatani K; Udaka T; Sogabe O; Maeda H; Mizuta M; Shirakawa K
Gan To Kagaku Ryoho; 2005 Dec; 32(13):2097-9. PubMed ID: 16352935
[TBL] [Abstract][Full Text] [Related]
15. Combination intraventricular chemotherapy for meningeal neoplasia.
Giannone L; Greco FA; Hainsworth JD
J Clin Oncol; 1986 Jan; 4(1):68-73. PubMed ID: 3079822
[TBL] [Abstract][Full Text] [Related]
16. First human treatment of resistant neoplastic meningitis by intrathecal administration of MTX plus (125)IUdR.
Rebischung C; Hoffmann D; Stefani L; Desruet MD; Wang K; Adelstein SJ; Artignan X; Vincent F; Gauchez AS; Zhang H; Fagret D; Vuillez J; Kassis AI; Balosso J
Int J Radiat Biol; 2008 Dec; 84(12):1123-9. PubMed ID: 19061137
[TBL] [Abstract][Full Text] [Related]
17. CSF infections complicating the management of neoplastic meningitis. Clinical features and results of therapy.
Trump DL; Grossman SA; Thompson G; Murray K
Arch Intern Med; 1982 Mar; 142(3):583-6. PubMed ID: 6802096
[TBL] [Abstract][Full Text] [Related]
18. Pediatric leptomeningeal metastases: outcome following combined therapy.
Chamberlain MC
J Child Neurol; 1997 Jan; 12(1):53-9. PubMed ID: 9010796
[TBL] [Abstract][Full Text] [Related]
19. Leptomeningeal metastasis.
DeAngelis LM; Boutros D
Cancer Invest; 2005; 23(2):145-54. PubMed ID: 15813508
[TBL] [Abstract][Full Text] [Related]
20. Intrathecal thiotepa: reappraisal of an established therapy.
Fisher PG; Kadan-Lottick NS; Korones DN
J Pediatr Hematol Oncol; 2002 May; 24(4):274-8. PubMed ID: 11972095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
